Robert S. Greenfield

2.1k total citations
43 papers, 1.3k citations indexed

About

Robert S. Greenfield is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology and Oncology. According to data from OpenAlex, Robert S. Greenfield has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Hematology and 9 papers in Oncology. Recurrent topics in Robert S. Greenfield's work include Blood Coagulation and Thrombosis Mechanisms (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Platelet Disorders and Treatments (6 papers). Robert S. Greenfield is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Platelet Disorders and Treatments (6 papers). Robert S. Greenfield collaborates with scholars based in United States, United Kingdom and Germany. Robert S. Greenfield's co-authors include Gary R. Braslawsky, Takushi Kaneko, David Willner, M A Edson, Satvir S. Tevethia, Jay O. Knipe, Pamela A. Trail, Shirley J. Lasch, Dalton King and Sandra J. Hofstead and has published in prestigious journals such as Circulation, Blood and The Journal of Immunology.

In The Last Decade

Robert S. Greenfield

42 papers receiving 1.2k citations

Peers

Robert S. Greenfield
Susan Wang United States
G. Stehle Germany
Koon Y. Pak United States
Verna Frasca United States
Olaf Kinstler United States
Marilynn Vetzel United States
Susan Wang United States
Robert S. Greenfield
Citations per year, relative to Robert S. Greenfield Robert S. Greenfield (= 1×) peers Susan Wang

Countries citing papers authored by Robert S. Greenfield

Since Specialization
Citations

This map shows the geographic impact of Robert S. Greenfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert S. Greenfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert S. Greenfield more than expected).

Fields of papers citing papers by Robert S. Greenfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert S. Greenfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert S. Greenfield. The network helps show where Robert S. Greenfield may publish in the future.

Co-authorship network of co-authors of Robert S. Greenfield

This figure shows the co-authorship network connecting the top 25 collaborators of Robert S. Greenfield. A scholar is included among the top collaborators of Robert S. Greenfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert S. Greenfield. Robert S. Greenfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Block, Robert, Frances Burke, Nihar R. Desai, et al.. (2023). Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study. Journal of clinical lipidology. 17(5). 592–601. 2 indexed citations
2.
Jones, Nickolas M., et al.. (2020). The costs outweigh the benefits: seeing side-effects online may decrease adherence to statins. BMC Medical Informatics and Decision Making. 20(1). 197–197. 7 indexed citations
3.
Greenfield, Robert S., et al.. (2018). Signal Transduction Peptide of Tissue Factor Phosphorylated at Ser258 and the Unphosphorylated STP in Urine Are Potential Biomarkers for Bladder Cancer. Clinical Genitourinary Cancer. 17(2). e247–e257. 4 indexed citations
4.
Wong, Nathan D., Paul D. Rosenblit, & Robert S. Greenfield. (2017). Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond. Cardiovascular Diagnosis and Therapy. 67(1). S11–S20. 11 indexed citations
5.
Rodansky, Eva S., et al.. (2010). Inhibition of Endothelial Cell Tube Formation by ADAMTS13 Occurs Via Interaction with VEGF. Blood. 116(21). 4307–4307. 3 indexed citations
6.
Lwaleed, Bashir A., et al.. (2007). Seminal factor VII and factor VIIa: supporting evidence for the presence of an active tissue factor‐dependent coagulation pathway in human semen. International Journal of Andrology. 30(6). 543–549. 7 indexed citations
7.
Lwaleed, Bashir A., Robert S. Greenfield, James W. Hicks, Brian Birch, & Alan Cooper. (2005). Quantitation of Seminal Factor IX and Factor IXa in Fertile, Nonfertile, and Vasectomy Subjects: A Step Closer Toward Identifying a Functional Clotting System in Human Semen. Journal of Andrology. 26(1). 146–152. 9 indexed citations
8.
Lwaleed, Bashir A., et al.. (2005). Seminal tissue factor revisited. International Journal of Andrology. 29(2). 360–367. 6 indexed citations
9.
Greenfield, Robert S., Brian Birch, Alan Cooper, & Bashir A. Lwaleed. (2005). Does human semen contain a functional haemostatic system?. Thrombosis and Haemostasis. 93(5). 847–852. 14 indexed citations
10.
Lwaleed, Bashir A., et al.. (2005). Seminal Factor VIII and von Willebrand Factor: a possible role of the conventional clotting system in human semen?. International Journal of Andrology. 28(1). 31–38. 7 indexed citations
11.
Antović, Jovan P., Sam Schulman, In Bum Suh, Robert S. Greenfield, & M. Blombäck. (2004). Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?. Scandinavian Journal of Clinical and Laboratory Investigation. 64(8). 745–752. 6 indexed citations
12.
Greenfield, Robert S., Alistair W. Stewart, Brian Birch, Alan Cooper, & Bashir A. Lwaleed. (2004). Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thrombosis and Haemostasis. 92(10). 752–766. 42 indexed citations
13.
Kaneko, Takushi, David Willner, Ivo Monković, et al.. (1991). New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity. Bioconjugate Chemistry. 2(3). 133–141. 138 indexed citations
14.
Braslawsky, Gary R., Kathleen F. Kadow, Jay O. Knipe, et al.. (1991). Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity. Cancer Immunology Immunotherapy. 33(6). 367–374. 72 indexed citations
15.
Gawlak, Susan L., Peter A. Kiener, Gary R. Braslawsky, & Robert S. Greenfield. (1991). Homodimeric Forms of Bombesin Act as Potent Antagonists of Bombesin on Swiss 3T3 Cells. Growth Factors. 5(2). 159–170. 7 indexed citations
16.
Greenfield, Robert S., Takushi Kaneko, M A Edson, et al.. (1990). Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.. PubMed. 50(20). 6600–7. 163 indexed citations
17.
Braslawsky, Gary R., et al.. (1990). Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.. PubMed. 50(20). 6608–14. 62 indexed citations
18.
Greenfield, Robert S., et al.. (1989). Immunohistochemical and biochemical characterization of antisera raised to human tumor nucleoli. Journal of Cancer Research and Clinical Oncology. 115(4). 351–360. 1 indexed citations
19.
Greenfield, Robert S., et al.. (1986). Biochemical Analysis and Biological Activities of Immunoaffinity Purified Natural Murine Gamma Interferon (MuIFN-γ). Journal of Leukocyte Biology. 40(6). 665–676. 6 indexed citations
20.
Greenfield, Robert S., et al.. (1979). Biology of simian virus 40 (SV40) transplantation antigen (TrAg). Virology. 97(1). 32–41. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026